A product that removes the queue, not just the threat
High-speed sensors screen people in a fraction of a second, keeping crowds moving.
Evolv: Evolve or Stand Still
AI weapons detection that screens crowds at walking pace, built into a recurring subscription business.
NASDAQ:EVLV
$5.98+1.01%
Updated: Jun 30, 2026
Technology
smallusa
Bull & Bear Case
An overview of the main reasons to invest and the key risks involved.
Bull Case
A data flywheel that hardware alone can never copy
Four billion-plus scans train proprietary AI no rival can replicate.
A subscription engine built for compounding
Four-year contracts, recurring software, retention above 100%, repeat buyers everywhere.
Bear Case
Margins are compressing as the model shifts
Direct fulfilment drags gross margin down before recurring revenue catches up.
Growth leans on slow sales and legislation
High-touch selling and state mandates can both stall unpredictably.
Accounting history demands close watching
A disclosed control weakness follows a prior revenue restatement.
Executive Summary
Generating Returns Through A Safer World
Mass shootings and a steady drift toward screening at the entrance of almost every public building have turned weapons detection from a niche purchase into a structural growth market, with one research house putting the AI gun-detection opportunity above $2 billion. For fifty years the only tool was the metal detector, which beeps at a belt buckle and a pistol with equal certainty, forcing a queue and a guard with a wand. Most schools and venues looked at that trade-off and screened nothing at all.
Evolv Technologies (NASDAQ: EVLV) sells the alternative. Its system reads an electromagnetic field and uses AI trained on billions of real walk-throughs to tell a phone from a gun in a fraction of a second, so people do not stop or empty their pockets. A new management team has pulled hardware in-house, raised guidance repeatedly, and is compounding a recurring subscription base on four-year contracts. With around 1,300 customers, more than 10,000 units heading out the door by year-end and most revenue now recurring, the question for investors is whether screening like this stays optional or becomes standard.
Investment Thesis
Overview of buy and sell case of the business.
Why Invest?
Key pieces of information about the business that you need to know about.
A product that removes the queue, not just the threat
Evolv's edge is not a better metal detector; it is a doorway that can tell harmless objects from weapons. The system flags concealed firearms, large knives and improvised explosives without making people stop, while its Redbox feature shows guards exactly where an object sits on the body, turning a frightening pat-down into a calm, specific question. That experience is why communities tend to accept screening rather than fight it, and why customers who install it usually expand it. It is the difference between safety bought with a bottleneck and safety that fits how people actually move.
A data flywheel that hardware alone can never copy
Evolv's systems have screened more than four billion people since 2019 and now scan over four million per day. Every walk-through feeds the AI models, making the next decision sharper in a way a static metal detector cannot match. Management is steering this toward a domain-specific model for concealed-weapon detection, and because the data is only usable alongside Evolv's own hardware and software, it is proprietary by design. The longer the install base runs, the wider this advantage grows, which is the heart of the competitive case.
A subscription engine built for compounding
The commercial model is designed for the long game. Most revenue is now recurring, sitting on four-year contracts with a software layer on top, and a 2026 pricing change deliberately shifts more value into recurring software and services. Retention does the talking: net revenue and net unit retention both run above 100%, roughly a third of customers have bought more, and a third of those have come back three or more times. Land, expand, expand again. The newer Expedite bag scanner adds a second product to cross-sell, attached to a small share of the base today but a far larger share of new wins.
Catalysts
The key events that could drive investment opportunities and shift markets.
Legislation turning optional into standard: Bills such as Georgia's would require screening at school entrances, funded from existing safety grants, giving other states an easy template.
Continued guidance beats: Q1 2026 revenue rose 45% to $46.3m with ARR of $127.3m; further raises would reinforce the recurring-revenue story.
New verticals opening up: Healthcare is largely unscreened, and Evolv is now the American Hospital Association's preferred provider across 500-plus hospital buildings.
Expedite cross-sell and enterprise scale: The bag scanner attaches to a growing share of new logos, while office wins like Bank of America point to enterprise demand.
A clear five-year plan to triple the business: Management targets $500m-plus revenue by 2031, around 25% annual growth, alongside a "Rule of 50" profile balancing growth and profit.
Penetration of a near-empty market: With roughly 700,000 priority entryways worldwide barely touched, small adoption gains compound into large recurring revenue.
Key Risks
Key pieces of information about the business risks that you need to know about.
Accounting history demands close watching
The FY2025 annual report disclosed a material weakness in internal controls, and this follows an earlier revenue-recognition restatement that damaged confidence in 2024. Roughly 200 larger public companies carry similar disclosures and remediation is underway, but given Evolv's specific past, investors will want to see the issue closed out. Thin sell-side coverage adds to the risk, since sentiment can swing on limited information.
Margins are compressing as the model shifts
Bringing hardware fulfilment in-house captures more value over a contract's life, but it front-loads cost. First-quarter 2026 gross margin fell to roughly the low fifties from the low sixties a year earlier, and management has flagged further pressure against 2025 levels before the recurring base offsets it. The stock fell sharply on the print despite a revenue beat, showing how closely the market is watching this line. The payoff depends on margins recovering over the next several quarters, which is not yet proven.
Growth leans on slow sales and legislation
Evolv sells one customer at a time through a high-touch process, which caps how fast it can scale. Part of the demand story also rests on state-level mandates and public-sector budgets, which can stall, get cut or meet political resistance. Independent school-safety experts caution that mandates often arrive underfunded and that technology is only one layer of a safety plan. Without legislative momentum and larger enterprise deals, adoption could lag the very large addressable market.
Follow the Experts
Quickly navigate key insights from industry experts and leverage their knowledge and market intelligence.
Expert Insights
x
'$EVLV not investment advice '26 color on today's call: sell even more units next year than this year (~1,950). Implies 24% growth in subscriptions --> at least 24% ARR in 2026. Conservative? First '25 guide given in May: 20-25% rev growth New '25 guide today: 37-40% rev growth'
Expert Insights
podcasts
"You will see them at all the stadiums, Six Flags etc, and they just continue to grow"
Expert Insights
x
"In the first year of Evolv scanners, no guns were brought to Prince William County Schools, with a 93% clearance rate. In year two, they will be used at all varsity boys basketball and football games"
Expert Insights
x
"We need to protect our youth and our schools from these threats from ever happening again. All school districts need to add @EvolvTechnology Express weapon detection sensors in every building"
Investor Materials
Access the most recent investor updates published by the company.
Company Materials
Evolv Technology Q1 2026
ArticleEvolv to launch new physical and digital security products at Global Security Exchange (GSX) conference New bag scanner does not require removal…...
Evolv Technology Reports FY25
PDFAnnual Report
PDFEvolv technology
Evolv eXpedite™ Achieves SAFETY Act Designation, Joining Evolv Express® as Qualified Anti-Terrorism Technology
ArticleWALTHAM, Mass.--(BUSINESS WIRE)-- Evolv Technology (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed…...
Evolv Technology and Philadelphia Phillies Expand Partnership with Multi-Year Renewal of Evolv Express®
PDFBank of America Stadium Reports Efficient Game-Day Operations Using Evolv Technology
PDFExternal Insights
A curated collection of third-party content relevant to the company and sector to help inform your investment decision.
Security Technology
Washington Post Article
ArticleResearch
Team
Meet the experienced professionals leading our organization
John Kedzierski
Anil Chitkara
Chris Kutsor
Neil Glat
What the Pros are asking
Here are the questions that professional investors are asking before making an investment decision.
Is the recurring-revenue model real, or just relabelled hardware sales?
Bulls point to ARR of $127.3m, up 20%, most revenue now recurring, and a 2026 pricing change that deliberately moves value into software and services. Retention metrics above 100% and a long backlog support the idea that this is a genuine subscription business. Sceptics note that a chunk of recent growth came from one-time product revenue as Evolv took fulfilment in-house, which flatters the top line. The honest read is that the recurring base is growing faster than total revenue, but it will take a few more quarters of ARR outpacing product sales to settle the debate.
When does Evolv actually make money?
The company is positive on adjusted EBITDA and guides to high single-digit margins for 2026, but it still posts GAAP losses, and the shift to direct fulfilment is compressing gross margin in the near term. Management argues that capturing more gross-profit dollars over each contract's life is worth the short-term hit, and that operating leverage will show as the install base scales. Bears counter that real, sustained profitability is more likely a 2027-2028 story. The evidence to watch is gross margin recovering toward the mid-fifties and operating expenses growing slower than revenue.
How big is the moat, really?
The strongest argument is the data: billions of scans that only work alongside Evolv's own hardware, feeding AI models that competitors cannot easily replicate. Two security heavyweights, with Axon and Motorola Solutions both represented around the company, lend credibility. Doubters point out that rivals like ZeroEyes, Omnilert and others are active, some with their own designations and verification services, and that Evolv is checkpoint-bound rather than wide-area. The moat looks real but is narrower than a true monopoly, which is why retention and repeat buying matter so much as evidence.
Does the technology actually work in the field?
Supporters cite real interceptions of firearms and knives at school entrances, plus demanding customers who tested the system themselves before renewing. Critics, including independent researchers, highlight false positives on everyday items and the lack of long-run peer-reviewed proof that any system prevents attacks. Both can be true at once. The practical question for investors is whether customers keep renewing and expanding despite imperfections, and so far the retention data suggests they do.
What turns this from a good product into a standard?
This is the crux of the thesis. Penetration is tiny, so the upside depends on screening becoming an expectation rather than an option, the way airbags and sprinklers did. Legislation, high-profile failures of older screening, and large wholesale orders from chains or enterprises would each push in that direction. The risk is that adoption stays slow and piecemeal. Investors are weighing a genuinely large market against a sales motion and regulatory path that move at their own pace.
Any questions?